—————————- Wall Street rises on Greek bets, Facebook falls 10 percent
- Apple CEO wants to make more products in U.S.
- Facebook shares plumb new depths, valuation questioned
- United Airlines pilots file race bias suit
- Chesapeake to meet with major lenders this week: sources
- Wells Fargo spending $432 million to end lending suit
- Bank of America whistleblower receives $14.5 million in mortgage case
Daily Archives: September 3, 2008
IPCM The Hospitalist Company 26.4
The Hospitalist Company, Inc., together with its subsidiaries, operates as a physician group practice company in the United States. It operates and manages hospitalist practices. The company provides a solution of clinical and management experience, proprietary technology, and care to … Continue reading
BITI Bio-Imaging Technologies 7.9
Bio-Imaging Technologies, Inc., together with its subsidiaries, provides services that support the product development process of the pharmaceutical, biotechnology, and medical device industries. It provides various services, including the processing and analysis of medical images, and the data-basing and regulatory … Continue reading
AIMC Altra Holdings 18.0
Altra Holdings, Inc., through its subsidiaries, designs, produces, and markets various mechanical power transmission and motion control products. Its product portfolio includes industrial clutches and brakes, enclosed gear drives, open gearing, engineered belted drives, couplings, engineered bearing assemblies, linear components, … Continue reading
Tagged AIMC
Leave a comment
ASGR America Service Group 11.0
America Service Group, Inc., through its subsidiaries, provides managed healthcare services to correctional facilities in the United States. The company contracts with state, county, and local governmental agencies to provide and/or administer healthcare services to inmates of prisons and jails. … Continue reading
Tagged ASGR
Leave a comment
DEPO Depomed 4.3
Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. The company’s product line comprises GLUMETZA for the treatment of type ii diabetes; ProQuin XR for uncomplicated … Continue reading
